Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.
Saved in:
| Title: | Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221. |
|---|---|
| Authors: | Chen CS; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA., Zirpoli G; Slone Epidemiology Center, Boston University, Boston, MA, USA., Budd GT; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Barlow WE; Cancer Research and Biostatistics, Seattle, WA, USA., Pusztai L; Yale School of Medicine, New Haven, CT, USA., Hortobagyi GN; Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Thompson A; Baylor College of Medicine, Houston, TX, USA., Henry NL; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Stringer KA; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA.; NMR Metabolomics Laboratory, University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA. dlhertz@med.umich.edu.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. dlhertz@med.umich.edu. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Aug; Vol. 94 (2), pp. 311-321. Date of Electronic Publication: 2024 May 30. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38814343 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chen+CS%22">Chen CS</searchLink>; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA.<br /><searchLink fieldCode="AU" term="%22Zirpoli+G%22">Zirpoli G</searchLink>; Slone Epidemiology Center, Boston University, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Budd+GT%22">Budd GT</searchLink>; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Barlow+WE%22">Barlow WE</searchLink>; Cancer Research and Biostatistics, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Hortobagyi+GN%22">Hortobagyi GN</searchLink>; Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA.<br /><searchLink fieldCode="AU" term="%22Godwin+AK%22">Godwin AK</searchLink>; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+A%22">Thompson A</searchLink>; Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Henry+NL%22">Henry NL</searchLink>; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Ambrosone+CB%22">Ambrosone CB</searchLink>; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Stringer+KA%22">Stringer KA</searchLink>; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA.; NMR Metabolomics Laboratory, University of Michigan College of Pharmacy, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Hertz+DL%22">Hertz DL</searchLink>; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA. dlhertz@med.umich.edu.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. dlhertz@med.umich.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2024 Aug; Vol. 94 (2), pp. 311-321. <i>Date of Electronic Publication: </i>2024 May 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38814343 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00280-024-04680-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 311 Titles: – TitleFull: Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chen CS – PersonEntity: Name: NameFull: Zirpoli G – PersonEntity: Name: NameFull: Budd GT – PersonEntity: Name: NameFull: Barlow WE – PersonEntity: Name: NameFull: Pusztai L – PersonEntity: Name: NameFull: Hortobagyi GN – PersonEntity: Name: NameFull: Albain KS – PersonEntity: Name: NameFull: Godwin AK – PersonEntity: Name: NameFull: Thompson A – PersonEntity: Name: NameFull: Henry NL – PersonEntity: Name: NameFull: Ambrosone CB – PersonEntity: Name: NameFull: Stringer KA – PersonEntity: Name: NameFull: Hertz DL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1432-0843 Numbering: – Type: volume Value: 94 – Type: issue Value: 2 Titles: – TitleFull: Cancer chemotherapy and pharmacology Type: main |
| ResultId | 1 |